S.SrikantaB

Disclosures: Felice Cinque: Nothing to Disclose, Andrea Dalbeni: Nothing to Disclose, Annalisa Cespiati: Nothing to Disclose, Floriana Santomenna: Nothing to Disclose, Jaqueline Curr: Nothing to Disclose, Daniel Smith: Nothing to Disclose, Erika Fatta: Nothing to Disclose, Cristina Bertelli: Nothing to Disclose, Giovanna Oberti: Nothing to Disclose, Giuseppina Pisano: Nothing to Disclose, Gabriele Maffi: Nothing to Disclose, Edoardo Pulixi: Nothing to Disclose, Alessandro Mantovani: Nothing to Disclose, Mirko Zoncap: Nothing to Disclose, David Sacerdoti: Nothing to Disclose, Anna Fracanzani: Nothing to Disclose, Rosa Lombardi: Nothing to Disclose 1130 ASSOCIATION OF BMI TRAJECTORY WITH MORTALITY AMONG NON-ALCOHOLIC FATTY LIVER DISEASE INDIVIDUALS: A PROSPECTIVE COHORT STUDY Junping Shi 1 Pengwei Zhang 1 Xianhui Dong 1 Yixuan Zhu 2 Run zhou 1 Fajuan Rui 2 Jie Li 2 Li Li 1 , 1 The Affiliated Hospital of Hangzhou Normal University, 2 Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School Background: Weight is a dynamically changing physiological indicator, the relationship between historical weight trends and mortality in patients with Non-alcoholic fatty liver disease (NAFLD) remains unclear

Homocystinuria Homocystinuria is a metabolic disorder that was discovered in the 1960s independently in the US and Ireland by observations of elevated homocystine (the disulfide of homocysteine) levels in the urine of mentally retarded individuals [16,17]
It is commonly used in laboratory research settings where sterile dilution or reconstitution of compounds is required